Breaking News, Promotions & Moves

J&J CEO Alex Gorsky to Step Aside

Company will transition the CEO role to Joaquin Duato at the start of 2022.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Johnson & Johnson has announced that Alex Gorsky, current chairman and CEO, is stepping aside effective January 3, 2022. The company will transition the chief executive role to Joaquin Duato, currently vice chairman of the company’s executive committee—he will also be appointed as a member of the company’s board.   Mr. Duato’s 30-plus year career at Johnson & Johnson has spanned multiple business sectors, geographies and functions. As vice chairman of the executive committee, he provides...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters